Physician profile
John Miller
NPI 1306075734
$106,405.30
in general payments reported to CMS, 2019-2025
18 companies · $3,980 in 2025
The $3,980 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $4,828 · 2021: $1,180 · 2022: $29K · 2023: $30K · 2024: $24K · 2025: $3,980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $44K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,440 · Food and Beverage: $4,206 · Travel and Lodging: $3,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $44,082.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,440.00 |
| Food and Beverage | $4,205.90 |
| Travel and Lodging | $3,631.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $79,896.29 | 2019-2025 | Constellation, Ngenuity, Viscoat |
| Carl Zeiss Meditec, INC. | $9,461.22 | 2019-2024 | Forum, Veracity Surgical, Clarus |
| Alcon Research LLC | $9,200.00 | 2022-2025 | Unity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,993.60 | 2023 | |
| Topcon Healthcare, INC. | $2,500.00 | 2022 | |
| Sunovion Pharmaceuticals INC. | $1,225.00 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $436.22 | 2019-2024 | Eylea Hd |
| Samsara Vision | $146.85 | 2025 | Implantable Miniature Telescope (Imt By Dr. Isaac Lipshitz) |
| Regeneron Pharmaceuticals, INC. | $106.88 | 2019 | |
| Genentech, INC. | $78.24 | 2021-2022 | |
| Genentech USA, INC. | $72.12 | 2019-2022 | |
| Optos, INC. | $71.51 | 2019 | |
| Boston Scientific Corporation | $56.14 | 2025 | Overstitch Endoscopic Suturing System |
| Apellis Pharmaceuticals, INC. | $55.84 | 2022 | |
| Alimera Sciences, INC. | $31.20 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optovue, INC. | $26.44 | 2020 | |
| Neurotech Pharmaceuticals, INC. | $24.27 | 2025 | |
| Novartis Pharmaceuticals Corporation | $23.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.